OOIR: Observatory of International Research

Papers

(The TQCC of Pediatric Blood & Cancer is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype	91
Brochure intervention to manage bothersome taste changes in pediatric patients receiving cancer therapy	52
Palliative care and suicidality: Complicated conversations at two ends of the spectrum	50
	48
Fatal brainstem injury following proton radiation in a patient with medulloblastoma and a germline variant in RNF213	45
How we approach complex vascular anomalies and overgrowth syndromes	43
The Ukrainian children emergency: How the Pediatric Oncology Unit of Turin supports cancer patients and their families who have escaped war	42
Emicizumab in Previously Untreated Patients and Minimally Treated Patients With Hemophilia A: A Comparative Study Between Two International Cohorts	41
Urgent Chemotherapy for Swift Symptom Relief in Patients With Medulloblastoma	38
Response assessment by positron emission tomography‐computed tomography as compared with contrast‐enhanced computed tomography in childhood Hodgkin lymphoma can reduce the need for radiotherapy in low	36
Efficacy of dual‐task training on stability and function in children with ataxia after medulloblastoma resection: A randomized controlled trial	35
Refractory thrombocytopenia and myelofibrosis in a novel KDSR mutation: Case report and literature review	31
Prevalence of Duffy null and its impact on hydroxyurea in young children with sickle cell disease in the United States	31
Pediatric erythroblastic transformation of JAK2‐mutated prefibrotic primary myelofibrosis with concurrent PHF6 mutations	29
Neonatal giant axillary hemangioma with subclavian arteriovenous fistula and heart failure	29
ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant	27
The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta‐analysis	26
Impact of Food Insecurity on Malnutrition Treatment Response in Nigerian Children With Sickle Cell Anemia and Severe Acute Malnutrition	25
Bloodletting as Medical Child Abuse Revealed by Lack of Iron Accumulation Despite Multiple Erythrocyte Transfusions	25
Image‐Guided Biopsy for the Diagnosis and Molecular Profiling of Hepatoblastoma	25
Bone mineral density in primarily preadolescent children with hemoglobin E/β‐thalassemia with different severities and transfusion requirements	24
A three‐year‐old with central nervous system graft versus host disease: A rare cause of posthematopoietic stem cell transplant encephalopathy	23
Strategies for the Treatment of Desmoplastic Small Round Cell Tumor: A Case Series	23
Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy	23
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors	23

Luspatercept for non‐deletional hemoglobin H disease	23
Platelet changes and bleeding symptoms in children, adolescents, and adults with 22q11.2 deletion syndrome	22
High‐dose carboplatin–irinotecan–temozolomide is an effective salvage chemotherapy for relapsed or refractory neuroblastoma	22
Lactate dehydrogenase reflects the status of ultra‐high‐risk neuroblastoma in a child under treatment	21
Feasibility of treating pediatric intracranial germ cell tumors in a middle‐income country: The Jordanian experience	21
Recombinant von Willebrand factor for perioperative bleeding management in pediatric patient with allergy to plasma‐derived von Willebrand factor	21
Late‐onset lymphopenia during radiation is associated with an increased risk of tumor recurrence in newly diagnosed pediatric medulloblastoma	21
Global nLPHL One Working Group (GLOW) Research Roadmap for Nodular Lymphocyte‐Predominant Hodgkin Lymphoma	20
	20
Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Reg	20
Cabozantinib in children with recurrent diffuse gliomas	20
Shwachman–Diamond Syndrome Patient Progressing From Chronic Myelomonocytic Leukemia to Acute Myeloid Leukemia Within Two Months	20
No wrong decisions in an all‐wrong situation. A qualitative study on the lived experiences of families of children with diffuse intrinsic pontine glioma	20
	19
	19
Implementation of physical rehabilitation programs for children with cancer across low‐ and middle‐income countries: A need of the hour perspective	19
Metastatic and multiply relapsed SDH‐deficient GIST and paraganglioma displays clinical response to combined poly ADP‐ribose polymerase inhibition and temozolomide	19
After 75 Years of Methotrexate, Can Treatment Results Be Improved With Appropriate Folinic Acid Rescue?	18
Automating the treatment planning process for 3D‐conformal pediatric craniospinal irradiation therapy	18
Late mortality reduction among survivors of germ cell tumors in childhood and adolescence in Europe: A report from the PanCareSurFup cohort	18
A National Audit of Current UK Practice on the Use of Anti‐Emetics for Chemotherapy‐Induced Nausea and Vomiting in Children	18
Prognostic factors of sepsis in children with acute leukemia admitted to the pediatric intensive care unit	18
Mini‐hyper CVD + CRIB (condensed rituximab, inotuzumab ozogamicin, and blinatumomab) for refractory pediatric B‐acute lymphoblastic leukemia	18
Social determinants of neurocognitive and academic performance in sickle cell disease	18
Children's Oncology Group 2023 blueprint for research: Cancer care delivery research	18
Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016–2021: Successes and ongoing research priorities	17
Psychosexual functioning in cancer survivorship: What the pediatric oncologist needs to know	17
New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor Committee	17
Quality of life and late therapy effects in pediatric non‐Hodgkin lymphoma survivors: Insights from a single‐institution study	17
Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes	17
Central nervous system thrombosis in pediatric acute lymphoblastic leukemia in Turkey: A multicenter study	16
	16
Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplantation in Children: A Single Pediatric Center Experience	16
First‐Line Postremission Blinatumomab as Successful Toxicity‐Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia	16
Wiskott–Aldrich syndrome protein expression in female WAS carriers: A flow cytometry study from North India	16
Choriocarcinoma in neonates and infants: A severe but curable disease	16
Incidence and 5‐year survival of children and adolescents with hepatoblastoma in the United States	16
Feasibility of indocyanine green‐guided localization of pulmonary nodules in children with solid tumors	16
Benchmarks for Psychosocial Staffing in Pediatric Oncology: Implementing the Standards Together—Engaging Parents and Providers in Psychosocial Care (iSTEPPP) Study	16
Improving Implementation of the Psychosocial Standards of Care Together	16
B‐cell lymphoblastic leukemia in an adolescent with Dravet syndrome	15
Brentuximab vedotin as a single agent in the treatment of a pediatric primary cutaneous CD30⁺ lymphoproliferative disorder: A case report	15
Stomatocytes, a whistleblower for future familial cardiovascular events: Unraveling the diagnosis of sitosterolemia in an Indian family	15
Unraveling Juvenile Hyaline Fibromatosis: A Case of Novel ANTXR2 Mutations Associated with Subcutaneous Masses and Hydronephrosis	15
CIC–NUTM1 sarcoma in an 8‐year‐old female patient with a new fusion: A case report	15
Platelet transfusions in neonates—Unresolved aspects and future directions	15
Correction to: Applying the COM‐B model to patient‐reported barriers to medication adherence in pediatric acute lymphoblastic leukemia	15
Comment on: Incorporation of patient‐reported outcomes in early‐phase clinical trials for childhood and adolescent cancer	14
Posterior Mediastinal Tumor Presenting with Compressive Myelopathy: Uncommon Site for a Rare Tumor	14
Ring sideroblasts and macrocytic anemia in an infant: Clues to the diagnosis of Pearson syndrome	14

Corrigendum	14
Bone marrow hematoidin crystals in a pediatric patient with chondroblastic osteosarcoma	14
Paraneoplastic Ichthyosis Preceding the Diagnosis of Gluteal Rhabdomyosarcoma at Initial Presentation and Relapse	14
Allogenic haematopoeitic stem cell transplant as cure for severe transfusion‐dependent non‐dominant hereditary spherocytosis due to homozygous SPTA1 mutation	14
Case report: Dichloroacetate‐induced methaemoglobinaemia in a G6PD‐deficient neonate	14
Variant histology of pediatric nodular lymphocyte‐predominant Hodgkin lymphoma with IgD and CD30 expression	14
Diagnosis, monitoring, and management of pyruvate kinase deficiency in children	14
Epidemiology of clinically unsuspected venous thromboembolism in children with cancer: A population‐based study from Maritimes, Canada	14
Issue Information	14
Pediatric Mixed Phenotype Acute Leukemia With ETV6::ARNT Fusion Gene Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation	14
Parental Acceptance of Human Papillomavirus Vaccination Among Females Treated for Childhood Cancer and/or With Hematopoietic Stem Cell Transplantation: A Cross‐Sectional Study	14
Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor‐specific antibody prior to haploidentical transplantation	14
A qualitative exploration of parental caregivers’ experience caring for children who have survived medulloblastoma	14
Successful Erwinia asparaginase one‐bag rapid desensitization process in a pediatric patient with acute lymphoblastic leukemia	14
Novel ELANE mutation causing severe congenital neutropenia with unpredictable fluctuations in neutrophil counts	14
Assessment of Caregivers and Their Children With Cancer Regarding Information Provided by Healthcare Teams: Advancing Stages Toward the Creation of a Structured Education Program at the National Level	14
Incidence and survival for childhood cancer by endorsed non‐stage prognostic indicators in Australia	14
Uniting for Change: The GLOW Initiative and Its Impact on Nodular Lymphocyte‐Predominant Hodgkin Lymphoma	14
A proposed algorithm for evaluation and management of pediatric hemophilia patients who present to the emergency department with head trauma	14
Abnormal coronary hyperperfusion due to a giant hemangioendothelioma in fetal distress: A case report	14
	13
Survey of the use of traditional and complementary medicine among children with cancer at three hospitals in Cameroon	13
Inclusion of Optic Pathway and Hypothalamic Tumors in Prognostic Studies of Pilocytic Astrocytoma: Is It Justified?	13
Clinical characteristics and outcomes of SARS‐CoV‐2 infection in pediatric oncology patients in the province of Quebec	13
Use of Autologous Umbilical Cord Blood in Neonatal Cardiac Surgery: A European Survey of Current Practices and Perceptions	13
Refractory, fatal autoimmune hemolytic anemia due to ineffective thymic‐derived T‐cell reconstitution following allogeneic hematopoietic cell transplantation for hypomorphic RAG1 deficiency	13
The Role of Perceived Health‐Related Information Adequacy in the Experiences of Parents of Children With Complex Vascular Anomalies	13
Concurrent carcinocythemia, chest wall and right knee joint involvement in Ewing sarcoma	13
A strategic approach to integration of spiritual care into the standards for the psychosocial care of children with cancer and their families	13
Wilms tumor characteristics, surgical management, outcomes, and chronic kidney disease in children with WAGR syndrome: A report from the International WAGR Syndrome Association survey	13
Treatment Landscape in Pediatric Immune Thrombocytopenia: Addressing Unmet Needs	13
Baseline Characteristics of Parents Enrolled in Children's Oncology Group Study ACCL20N1CD: Financial Toxicity During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States	13
Dyadic coping experiences of parents of children with vascular anomalies	13
Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity	13
Prognostic value of texture analysis of the primary tumour in high‐risk neuroblastoma: An ¹⁸F‐DOPA PET study	13
Diminished ovarian reserve in adolescent cancer survivors treated with heavy metal chemotherapy	13
Age‐ and sex‐specific rates of gall bladder disease in children with sickle cell disease	13
A Case of Blinatumomab Efficacy in RAM Immunophenotype/ CBFA2T3::GLIS2 Fusion AML	13
SNAP: Supportive non‐invasive ventilation for acute chest syndrome prevention for hospitalized children with sickle cell disease: Perspectives of patients, parents, and the healthcare team	13
Sarcopenia in long‐term survivors of cancer in childhood and adolescence: A cross‐sectional study of calf muscle mass by peripheral quantitative computed tomography with an examination of the muscle–b	13
Risk of Metabolic Syndrome and Glucose Homeostasis Among Childhood and Young Adult Acute Lymphoblastic Leukemia Survivors: Part of the ALL‐STAR Study	12
Clinical Practice Guideline for the Management of Communication and Swallowing in Children Diagnosed With Childhood Brain Tumor or Leukemia	12
Associations between Medicaid enrollment and diagnosis stage and survival among pediatric cancer patients	12
Malignant Rhabdoid Tumors of the Liver Are Associated With Inferior Outcomes Compared to Other Extracranial Rhabdoid Tumors	12
Dual Use of Skeletal Muscle Index and Body Mass Index Measured at the Time of Diagnosis Predicts Prognosis in Children With Malignant Solid Tumors: A Single‐Center Retrospective Study	12
Genetic characteristics and treatment outcome in infants with KMT2A germline B‐cell precursor acute lymphoblastic leukemia: Results of MLL‐Baby protocol	12
Issue Information	12
Erratum	12
Correction to “Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma”	12
Implementation science in pediatric oncology: A narrative review and future directions	12
Shifting perspectives and transformative change: Parent perspectives of an active music engagement intervention for themselves and their child with cancer	12
New therapeutics for children with sickle cell disease: A time for celebration, caution, or both?	12
Associations Between Pain Scores and Opioid Doses With Emergency Department Disposition and Return Visit Rates in Children With Sickle Cell Disease	12
Pre‐transplant glomerular hyperfiltration is not a risk factor for increased renal morbidity and mortality in pediatric stem cell transplant patients	12
How we approach coagulopathy with vascular anomalies	12
Image‐defined risk factors in localized thoracic neuroblastoma and ganglioneuroma	12
Fusion transcripts as liquid biopsy markers in alveolar rhabdomyosarcoma and synovial sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS)	12
Abstracts from the 39^th Annual Meeting of the Histiocyte Society	11
Spontaneous regression of a greater than 5 cm infant neuroblastoma after a three‐fold volume increase without life‐ or organ‐threatening features	11
Use of milrinone to support therapy‐induced heart failure through hematopoietic stem cell transplantation in a pediatric patient with high‐risk FLT3+ acute myeloid leukemia	11
Impact of magnetic resonance angiography parameters on stroke prevention therapy in pediatric patients with sickle cell anemia	11
Challenge implementing Pediatric Early Warning Systems to improve early identification of clinical deterioration in hospitalized children with cancer: Is it the score?	11
Correlation between asparaginase enzyme activity levels and coagulation parameters during childhood acute lymphoblastic leukemia treatment	11
Pediatric Acute B‐Lymphoblastic Leukemia Presenting as Hypereosinophilia With Lung Involvement and Elevated Immunoglobulin E Levels	11
Introduction to fertility preservation in pediatric patients with cancer: A report from the Children's Oncology Group	11
Socioeconomic Factors Associated With Participation in Postmortem Tissue Donation in Pediatric Central Nervous System Tumors	11
Daratumumab‐induced minimal residual disease negative remission in CD38 (dim)‐positive pediatric acute myeloid leukemia	11
Thalidomide‐associated autoimmune hemolytic anemia	11
Familial hemophagocytic lymphohistiocytosis onset as central diabetes insipidus in a child	11
De novo antiphospholipid antibody syndrome in two infants	11
The evidence is mounting: Insurance coverage disruptions lead to worse outcomes among children diagnosed with cancer	11
Prognostic value of chest x‐ray‐ and CT‐defined large mediastinal adenopathy in high‐risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831	11
A novel mobile health application to support cancer surveillance needs of patients and families with cancer predisposition syndromes	11
Cyclin D2 gene variance and expression level in pediatric acute lymphoblastic leukemia	11
Characterization of KMT2A::MATR3 fusion in a patient with acute lymphoblastic leukemia and monitoring of minimal residual disease by nanoplate digital PCR	11
FANCC and PTCH1 gene loss in congenital infantile rhabdomyosarcoma with spindle cell features	11
Contemporary surgical management of pediatric non‐rhabdomyosarcoma soft tissue sarcoma	10
Two Surveys, 16 Years Apart: Comparing Traditional and Complementary Medicine Use by Children With Cancer in Jordan	10
Pain mitigation and management strategies for anti‐GD2 infusions: An expert consensus	10
Feasibility of telehealth exercise and nicotinamide riboside supplementation in survivors of childhood cancer at risk for diabetes: A pilot randomized controlled trial	10

Complete response of metastatic alveolar soft part sarcoma in an adolescent female treated by combined immune checkpoint inhibitors	10
EZH2 is a key component of hepatoblastoma tumor cell growth	10
Continuous blood purification successfully treated severe cytokine release syndrome and immune effector cell‐associated neurotoxicity syndrome after chimeric antigen receptor T‐cell therapy: A case re	10
Behavioral and Electrophysiological Assessment of Central Auditory Processing in Individuals With Sickle Cell Disease	10
How we approach genetics in the diagnosis and management of vascular anomalies	10
Lack of benefit from premedication for pegylated asparaginase during pediatric acute lymphoblastic leukemia/lymphoma therapy: A side‐by‐side comparison	10
Chemo‐Immunotherapy Rescue for High‐Risk Neuroblastoma Patients With Progressive Disease Before High‐Dose Chemotherapy: Real‐World Data From the SACHA‐France Study	10
Atypical presentations of RECQL4‐related syndromes	10
Philadelphia chromosome‐like B‐acute lymphoblastic leukemia and disseminated juvenile xanthogranulomatosis with shared KRAS mutation	10
Blood counts in children with Down syndrome	10
Acute exacerbation of graft‐versus‐host disease following SARS‐CoV2 infection after hematopoietic stem cell transplant in two pediatric patients	10
Transatlantic progress in measurement of cognitive outcomes in paediatric oncology trials	10
Comment on: A Comparative Analysis of Clinical Utility of Cytogenetics and Copy‐Number–Integrated Risk Stratification Scores in a Prospective Cohort of Pediatric B‐Cell Acute Lymphoblastic Leukemia	10
Comprehensive fertility preservation can be offered in a timely manner around gonadotoxic therapy in children and adolescents	10
Addition of arm anthropometry to body mass index for age, but not serum albumin, improves the accuracy of the nutritional assessment in severely and moderately malnourished children with cancer	10
Post‐Transplant Cyclophosphamide for Graft‐Versus‐Host Disease Prophylaxis in Pediatric Stem Cell Transplantation	10
Marginal Zone B‐Cell Lymphoma With Marked Plasmacytic Differentiation and Increased Large Cells in a Teenage Male With Serine/Threonine Kinase‐4 Deficiency	10
Effects of a Low Versus Moderate–High Intense Exercise Program on Innate Immune Recovery, Fitness, and Quality of Life During Pediatric Allo‐HSCT—The ANIMAL Exploratory Randomized Controlled Trial	10
Comparison of transfusion reactions in children and adults: A systematic review and meta‐analysis	10
Spinal Atypical Teratoid/Rhabdoid Tumor with Metastatic Lesions in the Bilateral Acoustic Nerves	10
Longitudinal Patterns of Fatigue in Long‐Term Survivors of Childhood and Adolescent Cancers: A Report From the Swiss Childhood Cancer Survivor Study	10
Comment on: Trends in blood transfusion, hydroxyurea use, and iron overload among children with sickle cell disease enrolled in Medicaid, 2004–2019. Emerging therapeutic options for sickle cell anemia	10
B‐Lymphoblastic Leukemia With TCF3::PBX1 Fusion Presenting a Mature B‐Cell Phenotype and Lambda Light‐Chain Restriction	10
A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patients	10
Modern surgical strategies in pediatric neuroblastoma: Evolving approaches and treatment principles	10
Sirolimus for management of GI bleeding in blue rubber bleb nevus syndrome: A case series	10
Systemic Inflammatory Response Post Alemtuzumab and Low‐Dose Total Body Irradiation in Pediatric Patients With Sickle Cell Disease: A Case Series	9
A Retrospective Single‐Center Study of Ferric Derisomaltose in Adolescent Patients	9
	9
Provision of a personalized survivorship care plan and its impact on cancer‐related health literacy among childhood cancer survivors in Hong Kong	9
Results of a Randomized Augmented Intensification Phase in Acute Lymphoblastic Leukemia in Children in Argentina: GATLA 2010 ALL IC Trial	9
Reducing the Diagnostic Time for Childhood Cancer in Peru: A Hospital‐Based Registry Analysis Four Years After Implementation of the Global Initiative for Childhood Cancer	9
Clinic reported facilitators and barriers to pediatric cancer survivor care delivery among survivorship clinics: A fishbone analysis	9
NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocol	9
Coagulopathy and related complications following sclerotherapy of congenital venous malformations	9
An SRF‐rearranged malignant cellular myoid neoplasm with a novel SRF–MKL2 fusion	9
Intra‐abdominal desmoplastic small round cell tumor: The European pediatric Soft tissue sarcoma Study Group (EpSSG) experience	9
How we approach lymphedema in the pediatric population	9
Severe Precapillary Pulmonary Hypertension and Right Ventricular Failure After Hematopoietic Stem Cell Transplantation: Successful Outcomes With Aggressive Upfront Triple Therapy	9
Reply to: Comment on: Membrane‐type 1 matrix metalloproteinase as predictor of survival and candidate therapeutic target in Ewing sarcoma	9
	9
The quality and content analysis of YouTube videos about chemotherapy for children	9
Efficacy and safety of azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndromes before hematopoietic stem cell transplantation in the AZA‐JMML‐001 trial	9
Treatment of newly diagnosed severe aplastic anemia in children: Evidence‐based recommendations	9
Successful hematopoietic stem cell transplantation in MYH9‐related congenital thrombocytopenia	9
Primary Laparoscopic Nephrectomy for a Rare Renal Tumor in a Pediatric Patient	9
Treatment of high‐risk Hodgkin lymphoma with a modified Stanford V regimen in the AHOPCA: Substituting chemotherapy agents and hampered outcomes	9
Pediatric refractory immune thrombocytopenia: A systematic review	9
Neuroblastoma with neonatal cardiogenic shock and multiple‐organ failure: A rare association	9
Surgical aspects and outcomes after nephrectomy for Wilms tumour in sub‐Saharan Africa: A report from Wilms Africa Phase II—CANCaRe Africa	9
Long‐term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS)	9
Circumcision bleeding rates in patients diagnosed with delta‐storage pool deficiency later in life	9
Heterozygous TCF3‐related disease presenting as X‐linked agammaglobulinemia mimicry in a male toddler with B‐cell aplasia, agammaglobulinemia, and severe neutropenia	9
Hyperthyroidism following transplantation and SARS‐CoV‐2 exposure	9
Time to diagnosis among young patients with cancer	9
Pulmonary hypertension screening in children with sickle cell disease	9
Prevalence of neuropathic pain in adolescents with sickle cell disease: A single‐center experience	9
Contemporary Biology, Management, and Outcomes of Renal Medullary Carcinoma in Children and Adults: A Pediatric Surgical Oncology Research Collaborative Study	9
Anything to Help	9
Good engraftment after reduced intensity targeted busulfan‐based conditioning and matched related donor hematopoietic cell transplantation in hemoglobinopathies	9
Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single‐center case series	9
Cognitive predictors of social adjustment in pediatric brain tumor survivors treated with photon versus proton radiation therapy	9
Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high‐risk first relapse B‐cell precursor acute lymphoblastic leukemia	9
Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma	8
Rhabdoid tumor predisposition syndrome: A historical review of treatments and outcomes for associated pediatric malignancies	8
BRAF‐V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first‐line therapy	8
Myeloproliferative neoplasm with eosinophilia and PDGFR beta rearrangement in an infant	8
Integration of Metabolic Profiling and Functional Genomics Suggests IGJ as a Driver of Chemoresistance in B‐ALL	8
Factors associated with postoperative hypocalcemia following thyroidectomy in childhood	8
Cytarabine‐Related Neurotoxicity in an Infant With Acute Lymphoblastic Leukemia	8
A systematic review of combined surgery and brachytherapy approaches for children and young people with relapsed and refractory rhabdomyosarcoma (Local‐REFoRMS)	8
Sacrococcygeal teratoma: Long‐term outcomes. A UK CCLG Surgeons Group Nationwide Study	8
Episodes of acute methotrexate‐related neurotoxicity linked to compromised long‐term neurocognitive function	8
Feasibility of a prospective physiotherapy model of care during the intense treatment phase of childhood cancer (FITChild): A mixed methods design	8
Pediatric RISE: Development of a Poverty‐Targeted Cash Support Intervention for Pediatric Cancer	8
Development of a blueprint for sibling psychosocial services: A nationwide study	8
Excellent response to treatment with hydroxychloroquine in pediatric patients with SLE‐related immune thrombocytopenia	8
Use of gemcitabine, oxaliplatin, and anti‐CD20 therapy in children and adolescents with non‐Hodgkin lymphoma unfit for intensive therapy	8
A congenital CSF3R mutation in chronic neutropenia reveals a vital role for a cytokine receptor extracellular hinge motif in the response to granulocyte colony‐stimulating factor	8
Clinical Characteristics and Prognostic Analysis of Non‐ NPM1‐ALK Fusions in Pediatric Patients With ALK‐Positive Anaplastic Large‐Cell Lymphoma: A Singl	8
Evaluation of financial relationships between Japanese certified pediatric hematologist/oncologists and pharmaceutical companies: a cross‐sectional analysis of personal payments from pharmaceutical co	8
PAX–FOXO1 fusion status in children and adolescents with alveolar rhabdomyosarcoma: Impact on clinical, pathological, and survival features	8
Caregiver perceptions of child heath behaviors and weight during treatment for acute lymphoblastic leukemia	8
The pervasive influence of systems of power on transition readiness for adult care in sickle cell disease: A qualitative study	8
Second cancer risk in childhood cancer survivors treated with intensity‐modulated radiation therapy: An updated analysis of more than 10 years of follow‐up	8
Reducing ambulatory central line‐associated bloodstream infections: A family‐centered approach	8
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T‐acute lymphoblastic leukemia and T‐lymphoblastic lymphoma (study T2008‐002 NECTAR)	8
Prognostic value of hemogram parameters in osteosarcoma: The French OS2006 experience	8
A nomogram model to predict prognosis of patients with hepatoblastoma	8
Healthcare utilization and the quality of life of children and adolescents with sickle cell disease	8
The Global Prevalence of Iron Deficiency in Collegiate Athletes: A Systematic Review and Meta‐Analysis	8
Symptomatic osteonecrosis in children treated for Hodgkin lymphoma: A population‐based study in Sweden, Finland, and Denmark	8
Pulmonary embolism in pediatric and adolescent patients with COVID‐19 infection during the SARS‐CoV‐2 delta wave	8
“I was very scared when I found out my son had sickle cell”: Caregiver knowledge and attitudes toward early intervention for young children with sickle cell disease: Implications for policy and practi	8
Can virtual care reduce treatment burden in pediatric leukemia? A retrospective cost analysis	8